238 related articles for article (PubMed ID: 19857250)
1. Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.
Seliger B; Handke D; Schabel E; Bukur J; Lichtenfels R; Dammann R
J Transl Med; 2009 Oct; 7():90. PubMed ID: 19857250
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S
Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842
[TBL] [Abstract][Full Text] [Related]
4. CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma.
Kagara I; Enokida H; Kawakami K; Matsuda R; Toki K; Nishimura H; Chiyomaru T; Tatarano S; Itesako T; Kawamoto K; Nishiyama K; Seki N; Nakagawa M
J Urol; 2008 Jul; 180(1):343-51. PubMed ID: 18499164
[TBL] [Abstract][Full Text] [Related]
5. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
Kato N; Yamamoto H; Adachi Y; Ohashi H; Taniguchi H; Suzuki H; Nakazawa M; Kaneto H; Sasaki S; Imai K; Shinomura Y
World J Gastroenterol; 2013 Mar; 19(11):1718-27. PubMed ID: 23555160
[TBL] [Abstract][Full Text] [Related]
6. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Shang D; Han T; Xu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.
Xiang T; Li L; Yin X; Yuan C; Tan C; Su X; Xiong L; Putti TC; Oberst M; Kelly K; Ren G; Tao Q
PLoS One; 2012; 7(1):e29783. PubMed ID: 22279545
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration.
Seliger B; Fedorushchenko A; Brenner W; Ackermann A; Atkins D; Hanash S; Lichtenfels R
Clin Cancer Res; 2007 Jan; 13(1):27-37. PubMed ID: 17200335
[TBL] [Abstract][Full Text] [Related]
9. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer].
Yan WJ; Guo MZ; Yang YS
Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.
Wulfänger J; Biehl K; Tetzner A; Wild P; Ikenberg K; Meyer S; Seliger B
Int J Cancer; 2013 Dec; 133(11):2522-32. PubMed ID: 23686552
[TBL] [Abstract][Full Text] [Related]
11. Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.
Trifa F; Karray-Chouayekh S; Jmaa ZB; Jmal E; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Med Oncol; 2013 Mar; 30(1):418. PubMed ID: 23315218
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma.
Nanok C; Jearanaikoon P; Proungvitaya S; Limpaiboon T
Mol Med Rep; 2018 Mar; 17(3):4145-4153. PubMed ID: 29359783
[TBL] [Abstract][Full Text] [Related]
15. Silencing of the UCHL1 gene in giant cell tumors of bone.
Fellenberg J; Lehner B; Witte D
Int J Cancer; 2010 Oct; 127(8):1804-12. PubMed ID: 20104524
[TBL] [Abstract][Full Text] [Related]
16. Silencing of the UCHL1 gene in human colorectal and ovarian cancers.
Okochi-Takada E; Nakazawa K; Wakabayashi M; Mori A; Ichimura S; Yasugi T; Ushijima T
Int J Cancer; 2006 Sep; 119(6):1338-44. PubMed ID: 16642472
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of HOXA11, a novel functional tumor suppressor for renal cell carcinoma, is associated with RCC TNM classification.
Wang L; Cui Y; Sheng J; Yang Y; Kuang G; Fan Y; Jin J; Zhang Q
Oncotarget; 2017 Mar; 8(13):21861-21870. PubMed ID: 28423531
[TBL] [Abstract][Full Text] [Related]
18. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma.
Ashida S; Nishimori I; Tanimura M; Onishi S; Shuin T
J Cancer Res Clin Oncol; 2002 Oct; 128(10):561-8. PubMed ID: 12384800
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
20. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
Fukutomi S; Seki N; Koda K; Miyazaki M
Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
